. The Pasteur Institute online database (www.pasteur.fr/recherche/genopole/PF8/mlst/Kpneumoniae.html) was used to assign the allelic numbers and sequence type (ST).
To screen for the most commonly known β-lactamase genes in enterobacteria, we performed multiplex PCRs (10) . Primers were designed (NDM-F, 5′-AATGGAATTGCCCAATATT ATGC-3′; NDM-R, 5′-CGAAAGTCA GGCTGTGTTG C-3′) for the specifi c detection of bla NDM-1 and included in 1 of the multiplex PCRs (multiplex V). Primers NDM-F and NDM-R2 (5′-TCAGCGCAGCTTGTCGGC-3′) were used to amplify and sequence the entire bla NDM-1 gene. The samples were screened for the presence of six 16S methylase genes (armA, rmtA-D, and npmA) by PCR. E. coli J53 transconjugants were selected on Luria-Bertani plates containing sodium azide and meropenem (100 μg/mL and 1 μg/mL, respectively). The plasmid harboring bla NDM-1 was identifi ed by Southern blot analysis by using a specifi c digoxigenin-labeled bla NDM-1 probe (Roche Diagnostics, Indianapolis, IN, USA).
K. pneumoniae GN529 was highly resistant to all β-lactams, aminoglycosides, quinolones, tetracycline, nitrofurantoin, and co-trimoxazole. MICs of 0.5 μg/mL for colistin (European Committee on Antimicrobial Susceptibility Testing colistin breakpoint for Enterobacteriaceae: susceptibility <2 μg/mL) and 1 μg/mL for tigecycline (European Committee on Antimicrobial Susceptibility Testing and US Food and Drug Administration tigecycline breakpoint for Enterobacteriaceae: susceptibility <1 and <2 μg/mL, respectively) were also obtained (Table) .
Considering the travel history of the patient and the high level re- sistance to all β-lactams, molecular screening of β-lactamases in strain GN529 was initiated to identify possible carbapenemases (e.g., bla NDM-1 ) in that isolate. Five β-lactamases genes (bla NDM , bla SHV , bla TEM , group 1 bla CTX-M , and bla OXA ) and one 16S rRNA methylase (armA) were detected. By using primers for amplification of complete genes, we obtained sequences of bla NDM-1 , 2 extendedspectrum β-lactamases (bla CTX-M-15 and bla SHV-12 ), 3 broad-spectrum β-lactamases (bla SHV-11 , bla TEM-1 and bla OXA-1 ), and methyltransferase armA. No AmpC β-lactamases were linked to this isolate. Southern blotting identifi ed a plasmid of ≈150 kb harboring bla NDM-1 (data not shown). A transconjugant E. coli positive for bla NDM-1 (E. coli J529, Table) was resistant to all β-lactams and aminoglycosides tested. In addition, bla SHV-12 and armA were detected in strain J529 (Table) , indicating the potential for the horizontal spread of these resistance genes.
K. pneumoniae GN529 was typed by MLST as ST147, the same type as a clinical NDM-1-producing strain isolated in Australia (6) but distinct from ST14 and ST16 strains described (1, 7) . There are insuffi cient MLST data to confi rm polyclonal dissemination of NDM-1, but previous pulsedfi eld gel electrophoresis results support that hypothesis (2) .
K. pneumoniae GN529 was isolated from a patient who had recently received emergency medical care in India, suggesting importation of this clinical strain. In the United Kingdom, where Enterobacteriaceae containing bla NDM-1 are increasingly common, carriage of these organisms has been closely linked to receipt of medical care in the Indian subcontinent (2) . Similar association as a risk factor was observed in other regions, including bla NDM-1 -positive clinical strains isolated in North America, Australia, and Africa (3-6,10).
The NDM-1-producing enterobacteria described in this study previously had low MICs only for colistin and tigecycline (1, 2, 5, 6) . However, an NDM-1 isolate resistant to these antimicrobial drugs has also been described (2) . Early detection and implementation of infection control interventions is essential for preventing the spread of multidrug-resistant organisms such as these. It may be prudent to consider medical exposure in the Indian subcontinent as a risk factor for possible infection, colonization, or both with multidrug-resistant, NDM-1-producing Enterobacteriaceae.
